These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions. Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527 [TBL] [Abstract][Full Text] [Related]
16. Sensitivity of immune response quality to influenza helix 190 antigen structure displayed on a modular virus-like particle. Anggraeni MR; Connors NK; Wu Y; Chuan YP; Lua LH; Middelberg AP Vaccine; 2013 Sep; 31(40):4428-35. PubMed ID: 23845811 [TBL] [Abstract][Full Text] [Related]
17. Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus. Pushko P; Kort T; Nathan M; Pearce MB; Smith G; Tumpey TM Vaccine; 2010 Jul; 28(30):4771-6. PubMed ID: 20470801 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana. Shoji Y; Prokhnevsky A; Leffet B; Vetter N; Tottey S; Satinover S; Musiychuk K; Shamloul M; Norikane J; Jones RM; Chichester JA; Green BJ; Streatfield SJ; Yusibov V Hum Vaccin Immunother; 2015; 11(1):118-23. PubMed ID: 25483524 [TBL] [Abstract][Full Text] [Related]
19. The osmotic stress response of split influenza vaccine particles in an acidic environment. Choi HJ; Kim MC; Kang SM; Montemagno CD Arch Pharm Res; 2014 Dec; 37(12):1607-16. PubMed ID: 24101412 [TBL] [Abstract][Full Text] [Related]
20. Stabilization of HAC1 influenza vaccine by spray drying: formulation development and process scale-up. Zhu C; Shoji Y; McCray S; Burke M; Hartman CE; Chichester JA; Breit J; Yusibov V; Chen D; Lal M Pharm Res; 2014 Nov; 31(11):3006-18. PubMed ID: 24858396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]